Stock Code: Teyi Pharmaceutical Group Co.Ltd(002728) stock abbreviation: Teyi Pharmaceutical Group Co.Ltd(002728) Announcement No.: 2022031
Bond Code: 128025 bond abbreviation: Teyi convertible bond
Teyi Pharmaceutical Group Co.Ltd(002728)
Announcement on the resolution of the 27th meeting of the 4th board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
The 27th meeting of the 4th board of supervisors of Teyi Pharmaceutical Group Co.Ltd(002728) (hereinafter referred to as “the company”) was held in the meeting room of Teyi Pharmaceutical Group Co.Ltd(002728) company at 08:00 a.m. on May 4, 2022. There were 3 supervisors who should attend the meeting and 3 supervisors who actually attended the meeting. The convening and convening of the meeting was in accordance with the provisions of the company law and the articles of association of the company.
Mr. Zhang Mingjian, chairman of the board of supervisors of the company, presided over the meeting. The supervisors attending the meeting reviewed the relevant proposals and unanimously adopted the following resolutions:
1. The proposal on temporarily replenishing working capital by using some idle raised funds of convertible bonds was deliberated and adopted
The company has returned the funds raised for temporary replenishment of working capital. The board of supervisors agreed that the company could temporarily replenish working capital with idle raised capital of no more than RMB 100 million (accounting for 28.87% of the company’s net raised capital of 34635737667 yuan of convertible corporate bonds) on the premise of ensuring the capital demand of the investment project raised by convertible bonds, and the service life would be no more than 12 months from the date of handling the temporary replenishment of working capital after being deliberated and approved at the 27th meeting of the Fourth Board of directors. During the period of temporarily replenishing working capital with idle raised funds, no venture capital such as securities investment will be made, and the self owned funds will be returned to the special account for raised funds of the company at maturity.
The service life of the company’s idle raised funds to temporarily supplement the working capital shall not exceed 12 months, and the purpose of the raised funds shall not be changed or changed in a disguised form, which can reduce the company’s financial expenses and improve the efficiency of the use of funds, which is in line with the interests of all shareholders of the company, the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds of listed companies, and the company’s management system of raised funds.
Voting results: 3 in favor, 0 against and 0 abstention.
2. The proposal on adjusting the exercise price of 2021 stock option incentive plan was deliberated and adopted
After review, the board of supervisors believes that this adjustment is in line with the provisions of relevant laws and regulations such as the measures for the administration of equity incentives of listed companies, and there is no damage to the interests of the company and shareholders.
Voting results: 3 in favor, 0 against and 0 abstention.
It is hereby announced.
Teyi Pharmaceutical Group Co.Ltd(002728) board of supervisors may 5, 2022
